The Lancet
Vol. 404, Issue 10467, Pages 2021-2130
Date of Publication:
November 2024
Background: Diabetes can be detected at the primary health-care level, and effective treatments lower the risk of complications. There are insufficient data on the coverage of treatment for diabetes and how it has changed. We estimated trends from 1990 to 2022 in diabetes prevalence and treatment for 200 countries and territories.
Methods: We used data from 1108 population-representative studies with 141 million participants aged 18 years and older with measurements of fasting glucose and glycated haemoglobin (HbA1c), and information on diabetes treatment. We defined diabetes as having a fasting plasma glucose (FPG) of 7·0 mmol/L or higher, having an HbA1c of 6·5% or higher, or taking medication for diabetes. We defined diabetes treatment as the proportion of people with diabetes who were taking medication for diabetes. We analysed the data in a Bayesian hierarchical meta-regression model to estimate diabetes prevalence and treatment.
Citations
Zhou, Bin, Archie W. Rayner, Edward W. Gregg, Kate E. Sheffer, Rodrigo M. Carrillo-Larco, James Bennett, Jonathan E. Shaw, Christopher J. Paciorek, Rosie K. Singleton, Ana Barradas Pires, Goodarz Danaei, et al. Worldwide Trends in Diabetes Prevalence and Treatment from 1990 to 2022: A Pooled Analysis of 1108 Population-Representative Studies with 141 Million Participants. The Lancet 404 (10467): 2021-2130. November 2024.